327 related articles for article (PubMed ID: 35891252)
41. Association between risk perception and influenza vaccine hesitancy for children among reproductive women in China during the COVID-19 pandemic: a national online survey.
Du M; Tao L; Liu J
BMC Public Health; 2022 Feb; 22(1):385. PubMed ID: 35197035
[TBL] [Abstract][Full Text] [Related]
42. COVID-19 Vaccine Uptake, Hesitancy, and Flare in a Large Rheumatology Practice Network.
Holladay EE; Mudano AS; Xie F; Stewart P; Jackson LE; Danila MI; Gavigan K; Nowell WB; Venkatachalam S; Curtis JR
Arthritis Care Res (Hoboken); 2024 Jan; 76(1):111-119. PubMed ID: 37750035
[TBL] [Abstract][Full Text] [Related]
43. Attitudes and concerns regarding booster dose of COVID-19 vaccine among Egyptian patients with autoimmune and rheumatic diseases: a cross-sectional survey study.
Tharwat S; Eleraky ES; Adel T; Nassar MK; Saleh M
J Pharm Policy Pract; 2023 Apr; 16(1):54. PubMed ID: 37020249
[TBL] [Abstract][Full Text] [Related]
44. First COVID-19 Booster Dose in the General Population: A Systematic Review and Meta-Analysis of Willingness and Its Predictors.
Galanis P; Vraka I; Katsiroumpa A; Siskou O; Konstantakopoulou O; Katsoulas T; Mariolis-Sapsakos T; Kaitelidou D
Vaccines (Basel); 2022 Jul; 10(7):. PubMed ID: 35891260
[TBL] [Abstract][Full Text] [Related]
45. Predictors of Willingness of the General Public to Receive a Second COVID-19 Booster Dose or a New COVID-19 Vaccine: A Cross-Sectional Study in Greece.
Galanis P; Vraka I; Katsiroumpa A; Siskou O; Konstantakopoulou O; Katsoulas T; Mariolis-Sapsakos T; Kaitelidou D
Vaccines (Basel); 2022 Jun; 10(7):. PubMed ID: 35891225
[TBL] [Abstract][Full Text] [Related]
46. Qatar Healthcare Workers' COVID-19 Vaccine Hesitancy and Attitudes: A National Cross-Sectional Survey.
Kumar R; Alabdulla M; Elhassan NM; Reagu SM
Front Public Health; 2021; 9():727748. PubMed ID: 34513792
[No Abstract] [Full Text] [Related]
47. Predicting COVID-19 vaccine hesitancy in Hong Kong: Vaccine knowledge, risks from coronavirus, and risks and benefits of vaccination.
Tsang SJ
Vaccine X; 2022 Aug; 11():100164. PubMed ID: 35573268
[TBL] [Abstract][Full Text] [Related]
48. Receptiveness of American adults to COVID-19 vaccine boosters: A survey analysis.
Neely SR; Scacco JM
PEC Innov; 2022 Dec; 1():100019. PubMed ID: 35360835
[TBL] [Abstract][Full Text] [Related]
49. Using behavioral theory to understand partisan differences in COVID-19 vaccination and booster intentions.
Pavela G; Smith T; McDonald V; Bryan L; Riddle R
J Behav Med; 2024 Apr; 47(2):169-183. PubMed ID: 37659004
[TBL] [Abstract][Full Text] [Related]
50. COVID-19 vaccine and booster hesitation around the world: A literature review.
Shah A; Coiado OC
Front Med (Lausanne); 2022; 9():1054557. PubMed ID: 36714110
[TBL] [Abstract][Full Text] [Related]
51. Exploring the Willingness of the COVID-19 Vaccine Booster Shots in China Using the Health Belief Model: Web-Based Online Cross-Sectional Study.
Hu D; Liu Z; Gong L; Kong Y; Liu H; Wei C; Wu X; Zhu Q; Guo Y
Vaccines (Basel); 2022 Aug; 10(8):. PubMed ID: 36016224
[TBL] [Abstract][Full Text] [Related]
52. COVID-19 Vaccine Hesitancy and Attitude toward Booster Doses among US Healthcare Workers.
Pal S; Shekhar R; Kottewar S; Upadhyay S; Singh M; Pathak D; Kapuria D; Barrett E; Sheikh AB
Vaccines (Basel); 2021 Nov; 9(11):. PubMed ID: 34835289
[TBL] [Abstract][Full Text] [Related]
53. The Social Attitudes Towards the Booster Dose of the COVID-19 Vaccine and the Associated Factors Among Residents of Riyadh, Saudi Arabia.
Alyahya K; Almousa WY; Binsalamh LF; Alturaifi GA; Alabdely LH; Aljulaihim NF; Aldosari LM
Cureus; 2023 Oct; 15(10):e46556. PubMed ID: 37933360
[TBL] [Abstract][Full Text] [Related]
54. A cross-sectional study exploring the Covid-19 vaccination landscape in Malta through social media: An insight into experiences, attitudes, and perspectives.
Cuschieri S; Grech S; Grech V
Health Sci Rep; 2023 Jan; 6(1):e1014. PubMed ID: 36582628
[TBL] [Abstract][Full Text] [Related]
55. Perceived COVID-19 vaccine effectiveness, acceptance, and drivers of vaccination decision-making among the general adult population: A global survey of 20 countries.
Marzo RR; Ahmad A; Islam MS; Essar MY; Heidler P; King I; Thiyagarajan A; Jermsittiparsert K; Songwathana K; Younus DA; El-Abasiri RA; Bicer BK; Pham NT; Respati T; Fitriyana S; Faller EM; Baldonado AM; Billah MA; Aung Y; Hassan SM; Asad MM; El-Fass KA; Bhattacharya S; Shrestha S; Hamza NAE; Friedmann P; Head M; Lin Y; Yi S
PLoS Negl Trop Dis; 2022 Jan; 16(1):e0010103. PubMed ID: 35089917
[TBL] [Abstract][Full Text] [Related]
56. Sociodemographic and psychosocial factors associated with vaccine hesitancy - results from a longitudinal study in Singapore.
Subramaniam M; Abdin E; Shafie S; Shahwan S; Zhang Y; Satghare P; Devi F; Lun P; Yuxuan Ni M; Chong SA
Hum Vaccin Immunother; 2023 Aug; 19(2):2235964. PubMed ID: 37489273
[TBL] [Abstract][Full Text] [Related]
57. The Psychology of COVID-19 Booster Hesitancy, Acceptance and Resistance in Australia.
Kleitman S; Fullerton DJ; Law MKH; Blanchard MD; Campbell R; Tait MA; Schulz J; Lee J; Stankov L; King MT
Vaccines (Basel); 2023 Apr; 11(5):. PubMed ID: 37243011
[TBL] [Abstract][Full Text] [Related]
58. The Efficacy of a Brief, Altruism-Eliciting Video Intervention in Enhancing COVID-19 Vaccination Intentions Among a Population-Based Sample of Younger Adults: Randomized Controlled Trial.
Zhu P; Tatar O; Griffin-Mathieu G; Perez S; Haward B; Zimet G; Tunis M; Dubé È; Rosberger Z
JMIR Public Health Surveill; 2022 May; 8(5):e37328. PubMed ID: 35544437
[TBL] [Abstract][Full Text] [Related]
59. COVID-19 Vaccine-Related Attitudes and Beliefs in Canada: National Cross-sectional Survey and Cluster Analysis.
Benham JL; Atabati O; Oxoby RJ; Mourali M; Shaffer B; Sheikh H; Boucher JC; Constantinescu C; Parsons Leigh J; Ivers NM; Ratzan SC; Fullerton MM; Tang T; Manns BJ; Marshall DA; Hu J; Lang R
JMIR Public Health Surveill; 2021 Dec; 7(12):e30424. PubMed ID: 34779784
[TBL] [Abstract][Full Text] [Related]
60. Drivers of and Barriers to COVID-19 Vaccine Booster Dose Acceptance in Indonesia.
Harapan H; Fathima R; Kusuma HI; Anwar S; Nalapraya WY; Wibowo A; Wati KDK; Medina A; Defrita AH; Astri Y; Prasetyowati A; Nurfarahin N; Khusna A; Oktariana S; Anwar S; Yussar MO; Khotimah S; Nainggolan BWM; Badri PRA; Argarini R; Winardi W; Indah R; Sallam M; Rajamoorthy Y; Wagner AL; Mudatsir M
Vaccines (Basel); 2022 Nov; 10(12):. PubMed ID: 36560390
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
